Serum Institute of India
-
Opportunity India Desk Jun 22 2022 - 2 min readCervavac, developed by Serum Institute of India(SII) is likely to be the first indigenous qHPV vaccine to be approved in India. GlobalData, a leading data and analytics company, notes that this will not only make the drug more affordable to Indians, but will significantly help addressing the growing number of cervical cancer cases in the ...